Search - tctmd.com

Displaying 861 - 880 of 1146

Sort: Relevancy | Date

Presentation TCT 2016

Choose a Drug-Eluting Stent: Heres Why

Presenter: George D. Dangas, Fabio Felice Tarantino, Carlo Cernetti

November 01, 2016

Presentation TCT 2016

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did We Treat Our Patient?

Presenter: Roxana Mehran, Ferdinando Varbella, Alberto Menozzi

November 01, 2016

Presentation TCT 2016

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Dominick J. Angiolillo

November 01, 2016

Presentation TCT 2016

To Pretreat or Not to Pretreat? The DUBIUS Trial

Presenter: Roxana Mehran, Ferdinando Varbella, Giuseppe Tarantini

November 01, 2016

Presentation TCT 2016

Case Introduction: An Elderly Patient With NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Alberto Menozzi

November 01, 2016

News Industry News TCT 2016

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

November 01, 2016

Presentation TCT 2016

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Presenter: Sanjay Kaul, Jeffrey J. Popma, John D. Puskas

November 01, 2016

Presentation TCT 2016

Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Presenter: Sanjay Kaul, Jeffrey J. Popma, Michael Haude

November 01, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Presenter: Sanjay Kaul, Jeffrey J. Popma, Salvatore Cassese

November 01, 2016

Presentation TCT 2016

Opening Salvo: I Don't Believe That Door-to-Balloon Time Is a Critical Metric for Primary PCI In 2016!

Presenter: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung, Hitinder S. Gurm

November 01, 2016

Presentation TCT 2016

Opening Salvo: I Don't Believe That DAPT Should Be Continued Beyond 12 Months in Most Patients Undergoing PCI!

Presenter: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung, Gennaro Giustino

November 01, 2016

Presentation TCT 2016

Case #12: Magnesium BRS in Cross-Over Stenting

Presenter: Trine Ørhøj Barkholt

November 01, 2016

Presentation TCT 2016

Case #11: Kissing the Magnesium BRS

Presenter: Evald H. Christiansen

November 01, 2016

Presentation TCT 2016

Case #10: OCT Was Crucial Implanting BRS in This Bifurcation

Presenter: Jonathan M. Hill

November 01, 2016

Presentation TCT 2016

Case #9: Value of Self-Expanding Properties Using Desolve BRS in a Bifurcation

Presenter: Niels R. Holm

November 01, 2016

Presentation TCT 2016

Case #8: Absorb and Permanent DES in an LMCA Bifurcation With 3-year Follow-up

Presenter: Indulis Kumsars

November 01, 2016

Presentation TCT 2016

Case #7: All the Steps for This Absorb BRS Implanted in a Bifurcation

Presenter: Andreas Kristensen

November 01, 2016

Presentation TCT 2016

Rationale and Experience With the Pharmacoinvasive Strategy in STEMI

Presenter: Vinay K. Bahl, Amal Kumar Banerjee, Narenda N. Khanna, Upendra Kaul

November 01, 2016

Advertisement

Choose a Drug-Eluting Stent: Heres Why

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Case Conclusion: How Did We Treat Our Patient?

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

To Pretreat or Not to Pretreat? The DUBIUS Trial

Case Introduction: An Elderly Patient With NSTE-ACS

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Opening Salvo: I Don't Believe That Door-to-Balloon Time Is a Critical Metric for Primary PCI In 2016!

Opening Salvo: I Don't Believe That DAPT Should Be Continued Beyond 12 Months in Most Patients Undergoing PCI!

Case #12: Magnesium BRS in Cross-Over Stenting

Case #11: Kissing the Magnesium BRS

Case #10: OCT Was Crucial Implanting BRS in This Bifurcation

Case #9: Value of Self-Expanding Properties Using Desolve BRS in a Bifurcation

Case #8: Absorb and Permanent DES in an LMCA Bifurcation With 3-year Follow-up

Case #7: All the Steps for This Absorb BRS Implanted in a Bifurcation

Rationale and Experience With the Pharmacoinvasive Strategy in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content